Evogene Ltd. (EVGN) Form 8-K Material Events
Evogene Ltd. (EVGN) is a publicly traded company on the Nasdaq, categorized under SIC 2870 (Agricultural Chemicals). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: EVGN
CIK: 1574565
Exchange: Nasdaq
SIC 2870: Agricultural Chemicals
Fiscal Year End: 12/31
State: L3
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Kost Forer Gabbay & Kasierer
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerAsaf Vainer
Audit LocationTel Aviv, Israel
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13D/A | 2026-10-06 | — | SCHEDULE 13D/A Filing | 0001213900-26-107207 | View SEC Doc Filr Page |
| 6-K | 2026-10-06 | 2026-10-06 | 6-K | 0001178913-26-004722 | View SEC Doc Filr Page |
| 4 | 2026-09-30 | 2026-09-04 | 4 Filing | 0001178913-26-004664 | View SEC Doc Filr Page |
| 4 | 2026-09-30 | 2026-09-04 | 4 Filing | 0001178913-26-004662 | View SEC Doc Filr Page |
| 4 | 2026-09-30 | 2026-09-04 | 4 Filing | 0001178913-26-004660 | View SEC Doc Filr Page |
| 4 | 2026-09-30 | 2026-09-04 | 4 Filing | 0001178913-26-004658 | View SEC Doc Filr Page |
| 6-K | 2026-09-30 | 2026-09-30 | 6-K | 0001178913-26-004654 | View SEC Doc Filr Page |
| EFFECT | 2026-09-29 | — | EFFECT Filing | 9999999995-26-003086 | View SEC Doc Filr Page |
| 6-K | 2026-09-28 | 2026-06-30 | 6-K | 0001178913-26-004636 | View SEC Doc Filr Page |
| POS AM | 2026-09-28 | — | POS AM | 0001178913-26-004632 | View SEC Doc Filr Page |
| 6-K | 2026-09-15 | 2026-09-15 | 6-K | 0001178913-26-004516 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-09-11 | — | SCHEDULE 13D/A Filing | 0001213900-26-098957 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-09-11 | — | SCHEDULE 13D/A Filing | 0001178913-26-004496 | View SEC Doc Filr Page |
| 6-K | 2026-09-04 | 2026-09-04 | 6-K | 0001178913-26-004425 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-08-28 | — | SCHEDULE 13D/A Filing | 0001213900-26-094703 | View SEC Doc Filr Page |
| 6-K | 2026-08-27 | 2026-08-27 | 6-K | 0001178913-26-004270 | View SEC Doc Filr Page |
| 4 | 2026-08-26 | 2026-06-04 | 4 Filing | 0001178913-26-004259 | View SEC Doc Filr Page |
| 6-K | 2026-08-18 | 2026-08-18 | 6-K | 0001178913-26-004174 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001172661-26-003576 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-08-13 | — | SCHEDULE 13D/A Filing | 0001213900-26-088987 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-08-13 | — | SCHEDULE 13D/A Filing | 0001178913-26-004098 | View SEC Doc Filr Page |
| 4 | 2026-08-13 | 2026-08-11 | 4 Filing | 0001178913-26-004095 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-08-11 | — | SCHEDULE 13D Filing | 0001178913-26-004023 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-08-07 | — | SCHEDULE 13D/A Filing | 0001213900-26-086674 | View SEC Doc Filr Page |
| 4 | 2026-08-05 | 2026-08-04 | 4 Filing | 0001178913-26-003859 | View SEC Doc Filr Page |